home / stock / adhxd / adhxd short
Short Information | Fennec Pharmaceuticals Inc (OTCMKTS:ADHXD)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 0 |
Total Actual Volume | 0 |
Short Trends | |
---|---|
Cover Days | 0 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 0 |
Average Short Percentage | 0.00% |
Is there a ADHXD Short Squeeze or Breakout about to happen?
See the ADHXD Short Analysis for free Sign up or Login
Powered by Squeeze Report
News, Short Squeeze, Breakout and More Instantly...
Fennec Pharmaceuticals Inc Company Name:
ADHXD Stock Symbol:
OTCMKTS Market:
Fennec Pharmaceuticals Inc Website:
~ Achieved First Quarter 2024 Total Net Revenues of $25.4 Million, Including $18.0 Million in Licensing Revenue from Recently Announced Norgine Transaction ~ ~ Executed Exclusive Licensing Agreement with Norgine to Commercialize PEDMARQSI™ in Europe, Australia, ...
RESEARCH TRIANGLE PARK, N.C., May 07, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will release its first quarter 2024 financial results before the opening of the U.S. financial...
~ Achieved PEDMARK ® Full-Year 2023 Net Product Sales of $21.3 Million, Including $9.7 Million in Net Product Sales in the Fourth Quarter of 2023 ~ ~ Entered Into Exclusive Licensing Agreement to Commercialize PEDMARQSI™ in Europe, Australia and New Zealand for Appro...